Earlier today, Roche (RHHBY) presented new data on the use of Avastin in ovarian cancer. Other companies developing ovarian cancer drugs include Nektar Therapeutics (NKTR - Get Report) and Endocyte (ECYT - Get Report).
--Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here: Adam Feuerstein.
>To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein.
>To submit a news tip, send an email to: firstname.lastname@example.org.